Status:

UNKNOWN

Allogenic Stem Cell Therapy in Patients With Acute Burn

Lead Sponsor:

Shenzhen Beike Bio-Technology Co., Ltd.

Collaborating Sponsors:

The Second Affiliated Hospital of Kunming Medical University

Conditions:

Burns

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

PHASE2

Brief Summary

Burn trauma,especially extensive ones, remains a life-threatening local and general inflammatory condition destroying the skin and underlying tissues, and resulting in serious sequelae. Remarkable pro...

Detailed Description

To investigate the safety and efficacy of human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells transplantation in patients of Acute, Moderate-Severe, Full-thickness burn.

Eligibility Criteria

Inclusion

  • Between age 18- 65 years, both gender.
  • Diagnosed with Acute, Moderate-Severe, full-thickness burn:
  • Burn occurring within the 72 hours prior to administration. TBSA 20-55%, third degree wounds surface area \< 19 % ;
  • Willing to sign the Informed Consent Form.

Exclusion

  • All other burns except thermal origin.
  • Chronically malnourished, poor medical condition or shock
  • Systemic inflammatory response syndrome (SIRS) or septicopyemia
  • Moderate-severe inhalation injury airways to lung
  • HIV+
  • Autoimmune disease, e.g. lupus erythematosus, multiple sclerosis.
  • Severe pulmonary and hematological disease, malignancy or hypo-immunity.
  • Currently undertaking other treatment that may affect the safety/efficacy of stem cells.
  • Pregnancy or lactation
  • Enrollment in other trials in the last 3 months.
  • Other criteria the investigator consider improper for inclusion.

Key Trial Info

Start Date :

July 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2013

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01443689

Start Date

July 1 2011

End Date

July 1 2013

Last Update

November 28 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Second Affiliated Hospital of Kunmming Medical College

Kunming, Yunnan, China, 650033